Product Information
VALGANCICLOVIR 450 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $1.9150 per EA under NDC 00904679610. Its NADAC has been published 418 times since Oct 3, 2018.
FDA first approved this application on Mar 18, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
450 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904679610
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALGANCICLOVIR HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205166FDA Approved
3/18/2016
TE Code
AB
On Market Since
3/18/2016
Pharmacological Classes
Price Statistics
The NADAC for VALGANCICLOVIR 450 MG TABLET has been published 418 times since Oct 3, 2018, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9150 per EA |
|---|---|
| All-time high | $8.1258 (Nov 14, 2018) |
| All-time low | $1.7596 (Nov 20, 2024) |
| 52-week high | $2.5006 |
| 52-week low | $1.8426 |
| Median price | $2.9635 |
| Average price | $3.6322 |
| Largest weekly change | -36.9% (Feb 20, 2019) |
| Weeks tracked | 418 |
| Tracking since | Oct 3, 2018 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valganciclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALGANCICLOVIR 450 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR 450 MG TABLET, manufactured by Major Pharmaceuticals, is $1.9150 per EA (NDC 00904679610), effective Sep 30, 2026.
How has the price of VALGANCICLOVIR 450 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALGANCICLOVIR 450 MG TABLET has declined 72.9%. It has been tracked across 418 weekly CMS publications since Oct 3, 2018.
What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR 450 MG TABLET?
Since Oct 3, 2018, the NADAC for VALGANCICLOVIR 450 MG TABLET has ranged from a low of $1.7596 (Nov 20, 2024) to a high of $8.1258 (Nov 14, 2018), with a median of $2.9635 per EA.
Are there cheaper alternatives to VALGANCICLOVIR 450 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALGANCICLOVIR 450 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALGANCICLOVIR 450 MG TABLET?
VALGANCICLOVIR 450 MG TABLET (NDC 00904679610) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.